| Value | ₹4.76 Cr |
|---|---|
| Execution period | 15 to 18 months |
BSE filing, NSE: MOLDTECH. Summary written from the filing by ALFA Finder's alert engine.
Mold-Tek Technologies Ltd: key numbers
- Share price
- ₹89.48
- Market cap
- ₹515.5 Cr
- Revenue (annual)
- ₹181.7 Cr
- Net profit (annual)
- ₹10.09 Cr
- P/E (TTM)
- 28.0×Sector 32.2×
- Promoter holding
- 49.85%-0.62% QoQ
- FII holding
- 0.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mold-Tek Technologies Ltd
All →Mold-Tek Technologies Board Meeting Date
Mold-Tek Technologies will hold a board meeting on November 4, 2026 to consider unaudited standalone and consolidated results for the quarter and half-year ended September 30, 2026. The trading window stays closed until November 6, 2026.
Mold-Tek Technologies Other Announcement
The company has filed its quarterly shareholding pattern report as required under SEBI regulations. This routine disclosure details the distribution of equity among various shareholder categories.
Mold-Tek Technologies Bonus Issue
Mold-Tek Technologies Limited has allotted 2,88,05,118 fully paid-up bonus equity shares in a 1:1 ratio. This increases the company's paid-up equity capital to Rs. 11.52 Crore.
Mold-Tek Technologies Bonus Issue
Mold-Tek Technologies has fixed October 09, 2026, as the record date for its 1:1 bonus share issue. Eligible shareholders will receive one new share for every existing share held.
Mold-Tek Technologies Management Change
The company announced the re-appointment of Mrs. Madhuri Venkata Ramani Viswanadham as a Non-Executive Independent Director for a second five-year term, effective December 27, 2026.
Mold-Tek Technologies Annual General Meeting
Mold-Tek Technologies Ltd conducted its 42nd Annual General Meeting on September 21, 2026, transacting business including financial statements, dividends, director appointments, and bonus share issuance.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.